Catalog

Record Details

Catalog Search


Search Results Showing Item 1 of 1

Image of item

The antidote : inside the world of new pharma / Barry Werth.

Werth, Barry. (Author).
Book Book

Copies

Location: IAHS STACKS RA401 .A3 W47 2015
Barcode: 30731101161424
Status: Available

Record details

  • ISBN: 9781451655674
  • ISBN: 1451655673
  • Physical Description: x, 435 pages : illustrations ; 21 cm
  • Edition: First Simon & Schuster trade paperback edition
  • Publisher: New York : Simon & Schuster, 2015.

Content descriptions

Bibliography, etc. Note:
Includes bibliographical references and index.
Summary, etc.:
In 1989, the charismatic Joshua Boger left Merck, then America's most admired business, to found a drug company that would challenge industry giants and transform health care. Journalist Barry Werth described the company's tumultuous early days during the AIDS crisis in The Billion-Dollar Molecule, a celebrated classic of science and business journalism. Now he returns to tell the story of Vertex's bold endurance and eventual success. The pharmaceutical business is America's toughest and one of its most profitable. It's riskier and more rigorous at just about every stage than any other business, from the towering biological uncertainties inherent in its mission to treat disease; to the 30-to-1 failure rate in bringing out a successful medicine; to the multibillion-dollar cost of ramping up a successful product; to operating in the world's most regulated industry, matched only by nuclear power. Werth captures the full scope of Vertex's 25-year drive to deliver breakthrough medicines.-- From publisher description.
Subject: Vertex Pharmaceuticals Incorporated.
Drugs > Marketing.
aPharmaceutical industry > United States > History.
Pharmaceutical industry > United States.
LDR 00620cam a2200205Ki 4500
00162848
003MOHAWK
00520170410183432.0
008170410s2015 nyu eng d
020 . ‡a9781451655674 ‡qpaperback
020 . ‡a1451655673 ‡qpaperback
05004. ‡aRA401 .A3 ‡bW47 2015
1001 . ‡aWerth, Barry.
24500. ‡aThe antidote : ‡binside the world of new pharma / ‡cBarry Werth.
250 . ‡aFirst Simon & Schuster trade paperback edition
264 1. ‡aNew York : ‡bSimon & Schuster, ‡c2015.
300 . ‡ax, 435 pages : ‡billustrations ; ‡c21 cm
336 . ‡atext ‡btxt ‡2rdacontent
337 . ‡aunmediated ‡bn ‡2rdamedia
338 . ‡avolume ‡bnc ‡2rdacarrier
504 . ‡aIncludes bibliographical references and index.
520 . ‡aIn 1989, the charismatic Joshua Boger left Merck, then America's most admired business, to found a drug company that would challenge industry giants and transform health care. Journalist Barry Werth described the company's tumultuous early days during the AIDS crisis in The Billion-Dollar Molecule, a celebrated classic of science and business journalism. Now he returns to tell the story of Vertex's bold endurance and eventual success. The pharmaceutical business is America's toughest and one of its most profitable. It's riskier and more rigorous at just about every stage than any other business, from the towering biological uncertainties inherent in its mission to treat disease; to the 30-to-1 failure rate in bringing out a successful medicine; to the multibillion-dollar cost of ramping up a successful product; to operating in the world's most regulated industry, matched only by nuclear power. Werth captures the full scope of Vertex's 25-year drive to deliver breakthrough medicines.-- ‡cFrom publisher description.
61020. ‡aVertex Pharmaceuticals Incorporated.
650 0. ‡aDrugs ‡xMarketing.
650 0. ‡aaPharmaceutical industry ‡zUnited States ‡xHistory.
650 0. ‡aPharmaceutical industry ‡zUnited States.
990 . ‡aEngTech2016, BioTech2016, Pharm2016
995 . ‡aMT received from Amazon, March 2017, $19.80.
901 . ‡aAUTOGENERATED-5117 ‡b ‡c62848 ‡tbiblio ‡sSystem Local
Search Results Showing Item 1 of 1